Market Revenues For Biological And Medical Imaging Reagents To Cross $40 Billion By 2030, Driven By Rising Diagnostic Needs And Advanced Technologies

(MENAFN- GlobeNewsWire - Nasdaq) Emerging opportunities in biological and medical imaging reagents include rising diagnostic needs, AI integration, multiplex technologies, and nanotechnology advancements, driving market growth. Key players offer innovation and global reach, while ESG considerations are also shaping the competitive landscape.

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "Biological and Medical Imaging Reagents: Global Markets" has been added to ResearchAndMarkets's offering.

The global biological and medical imaging reagents market is predicted to expand significantly from $26.6 billion in 2025 to $40.1 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.6%. This growth is driven by an increasing demand for diagnostic solutions and advancements in drug development. Reagents utilized in this field include optical, nuclear, and contrast agents, each playing a pivotal role in visualizing molecular processes, enhancing early disease detection, and supporting multiplex technologies that simultaneously identify multiple infections.

Key industry players such as GE HealthCare, Thermo Fisher Scientific Inc., Siemens Healthineers, Bayer AG, and Becton, Dickinson and Co. (BD) maintain a strong market position through innovation and global reach. New players like Revvity Inc. and Bracco Imaging S.p.A. are also making their mark. Nanotechnology and the development of advanced fluorescent probes are key to the market's evolution, offering enhanced sensitivity, speed, and the capability for real-time, non-invasive cellular imaging.

Report Scope

The detailed report offers an extensive overview of the global biological and medical imaging reagent market and spotlights significant trends. Utilizing 2024 as a baseline, it forecasts revenue through 2030 and segments the market by type, modality, technology, application, end user, and region. It encompasses North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America, focusing on key countries within these regions.

The study delves into the driving factors and emerging tech shaping the market and vendor landscape, examines environmental, social, and corporate governance (ESG) developments, and discusses patents and technological advances. The report concludes with a competitive landscape analysis, which ranks leading companies and provides detailed company profiles.

The report includes:

• 109 data tables and 68 additional tables
• A comprehensive overview of the market's trends from 2022 to 2024, with estimates for 2025 and CAGR projections through 2030
• Insights on market growth prospects, analyzing product types, modalities, technologies, applications, end users, and regions
• An examination of diagnostic methods' classifications, comparisons, and future demand within this industry, along with a thorough analysis of the competitive environment, market regulations, and reimbursement practices
• An analysis of patents, emphasizing emerging technologies and new developments
• A discussion on ESG challenges and industry practices
• Market share analysis of key industry players, focusing on proprietary technologies, strategic alliances, and market strategies
• Comprehensive company profiles of leading market players, including GE HealthCare, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG, and Becton, Dickinson and Co. (BD)

Key Attributes

Report Attribute	Details
No. of Pages	192
Forecast Period	2025-2030
Estimated Market Value (USD) in 2025	$26.6 Billion
Forecasted Market Value (USD) by 2030	$40.1 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global

Key Topics Covered:

• Chapter 1 Executive Summary
  • Market Outlook
  • Scope of the Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion
• Chapter 2 Market Overview
  • Overview
  • Forces Driving Industry Growth
  • Porter's Five Forces Analysis
  • Macroeconomic Factors Analysis
  • Prevalence of Chronic Diseases and Rising Investments
  • Impact of U.S. Tariff
• Chapter 3 Market Dynamics
  • Overview
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Market Challenges
• Chapter 4 Regulatory Landscape
  • Regulatory Approval Process, by Select Country/Region
• Chapter 5 Emerging Technologies and Developments
  • Key Takeaways
  • Nanoparticles
  • Next-Generation Imaging Reagents
  • AI and ML in Imaging Reagents
  • Patent Analysis
• Chapter 6 Market Segment Analysis
  • Segmentation Breakdown
  • Market Analysis by Product Type
  • Market Analysis by Modality
  • Market Analysis by Technology
  • Market Analysis by Application
  • Market Analysis by End Use
  • Market Analysis by Region
• Chapter 7 Competitive Intelligence
  • Key Takeaways
  • Global Market Shares of Leading Companies
  • Key Developments and Strategies
• Chapter 8 Sustainability in Biological and Medical Imaging Reagents Market: ESG Perspective
  • Introduction to ESG
  • Steps Toward Sustainable Use
  • ESG Risk Ratings
• Chapter 9 Appendix
  • Methodology
  • Abbreviations
  • Company Profiles
    • Agilent Technologies Inc.
    • Altona Diagnostics GmbH
    • Analytik Jena GmbH+Co. KG
    • Bayer AG
    • BD
    • Bio-Rad Laboratories Inc.
    • Danaher Corp.
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare
    • Merck KGaA
    • Promega Corp.
    • Qiagen
    • Revvity
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Global Biological and Medical Imaging Reagents Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN23092025004107003653ID1110100522